{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:46:45Z","timestamp":1792511205829,"version":"4.5.0"},"reference-count":87,"publisher":"American Society for Microbiology","issue":"6","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["JRP13-AMRSH5-WORLDCOM"],"award-info":[{"award-number":["JRP13-AMRSH5-WORLDCOM"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Appl Environ Microbiol"],"published-print":{"date-parts":[[2025,6,18]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>\n              Antimicrobial resistance threatens human and animal health, with antimicrobial usage being a key driver of selection, transmission, and spread of resistant bacteria. Livestock represents a potential reservoir for human transmission, leading authorities to restrict veterinary usage of fluoroquinolones and certain cephalosporins. However, growing evidence indicates that the corresponding resistance determinants can be retained even in the drugs\u2019 absence. To obtain data on the magnitude and dynamics of this phenomenon in pig farming, we quantitatively and qualitatively assessed fluoroquinolone- and cephalosporin-resistant\n              <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n              in Thuringian pigsties practicing a closed management system to minimize the impact of externally introduced strains. Pooled fecal samples from consecutive fattening runs at one conventional and two organic farms and from 25 piglet groups from another conventional farm were collected over 16 months and screened for\n              <jats:italic toggle=\"yes\">E. coli<\/jats:italic>\n              on plates containing enrofloxacin, ceftiofur, or cefquinome. Resistant bacteria were isolated on all farms; their counts varied strongly but were generally higher in piglets and declined with increasing animal age. Phylogenetic comparison of 393 isolates was performed via multiple-locus variable number tandem repeat analysis (MLVA) to follow strain dynamics and persistence. The isolates displayed large phylogenetic heterogeneity, featuring 52 different MLVA patterns. Still, conserved MLVA patterns indicated long-term persistence of specific strains in each farm's environment. This suggests that resistant strains appear well-adapted to the particular farm and its management practices, implying that, beyond restricting usage, further measures, including, e.g., consideration of the type of resistance as well as its persistence and transmission dynamics, will be indispensable to reduce the antimicrobial resistance load in pork production.\n            <\/jats:p>\n            <jats:sec>\n              <jats:title>IMPORTANCE<\/jats:title>\n              <jats:p>\n                Antimicrobial resistance (AMR) represents a global threat to human and animal health, with animals considered a reservoir for transmission of AMR to humans. Because antimicrobial usage is a driver for resistance, one approach to decrease the AMR burden is to reduce its usage. However, this can, but does not necessarily, lead to lower AMR prevalence. German and EU legislation restrict the use of fluoroquinolones and certain cephalosporins, substance classes designated as highest priority critically important antimicrobials for human medicine, in animal husbandry. Longitudinal sampling of organic and conventional farms in Thuringia for resistance to these antibiotic classes revealed that certain resistant\n                <jats:italic toggle=\"yes\">Escherichia coli<\/jats:italic>\n                strains can persist in the farm environment over extended time periods. These strains displayed farm specificity, indicating adaptation to the particular farm and its management practices, so that their elimination might be difficult, requiring either procedures acting generally against Enterobacterales or targeted action against the specific strains.\n              <\/jats:p>\n            <\/jats:sec>\n          <\/jats:sec>","DOI":"10.1128\/aem.01386-24","type":"journal-article","created":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T13:00:12Z","timestamp":1746709212000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["<i>Escherichia coli<\/i>\n            resistant to the highest priority critically important fluoroquinolone or 3rd and 4th generation cephalosporin antibiotics persist in pigsties"],"prefix":"10.1128","volume":"91","author":[{"given":"Nicola M.","family":"Pfeifer","sequence":"first","affiliation":[{"name":"Friedrich-Loeffler-Institut, Institute of Molecular Pathogenesis","place":["Jena, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weber","sequence":"additional","affiliation":[{"name":"Friedrich-Loeffler-Institut, Institute of Molecular Pathogenesis","place":["Jena, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Wiegand","sequence":"additional","affiliation":[{"name":"Friedrich-Loeffler-Institut, Institute of Molecular Pathogenesis","place":["Jena, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie A.","family":"Barth","sequence":"additional","affiliation":[{"name":"Friedrich-Loeffler-Institut, Institute of Molecular Pathogenesis","place":["Jena, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7500-5864","authenticated-orcid":true,"given":"Christian","family":"Berens","sequence":"additional","affiliation":[{"name":"Friedrich-Loeffler-Institut, Institute of Molecular Pathogenesis","place":["Jena, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Menge","sequence":"additional","affiliation":[{"name":"Friedrich-Loeffler-Institut, Institute of Molecular Pathogenesis","place":["Jena, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00473-0"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/MMBR.00016-10"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30705-3"},{"key":"e_1_3_3_5_2","unstructured":"World Health Organization. 2020. 10 global health issues to track in 2021. Available from: https:\/\/www.who.int\/news-room\/spotlight\/10-global-health-issues-to-track-in-2021. Retrieved 20 Oct 2023."},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001359"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.18.2100611"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100521"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285170"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02724-0"},{"key":"e_1_3_3_11_2","volume-title":"Global action plan on antimicrobial resistance","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. Global action plan on antimicrobial resistance. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_3_12_2","volume-title":"Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. 2020. Global antimicrobial resistance surveillance system (GLASS) report: early implementation 2020. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10092-9"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao1495"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkz348"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3382\/ps\/pey539"},{"key":"e_1_3_3_17_2","unstructured":"Agency EM. 2022. Sales of veterinary antimicrobial agents in 31 European countries in 2021 \u2013 Trends from 2010 to 2021 \u2013 Twelfth ESVAC report. Publications Office of the European Union"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2012.03850.x"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00424-7"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-019-0445-2"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkp387"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00248-011-9954-0"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00037-19"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41396-018-0200-3"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1086\/321843"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41396-023-01509-7"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dky037"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000376"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00848-12"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2017.0226"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2014.01.036"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00177-15"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.ame-0014-2020"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-0416-x"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.ARBA-0026-2017"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1439-0450.2004.00775.x"},{"key":"e_1_3_3_37_2","volume-title":"Critically important antimicrobials for human medicine, 6th revision","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. 2019. Critically important antimicrobials for human medicine, 6th revision. World Health Organization, Geneva, Switzerland."},{"key":"e_1_3_3_38_2","unstructured":"Agency EM. 2020. Categorisation of antibiotics in the European Union - Answer to the request from the European Commission for updating the scientific advice on the impact on public health and animal health of the use of antibiotics in animals. Amsterdam The Netherlands European Medicines Ageny"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2023.106473"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9100678"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02612-20"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-49-5-397"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2021.6490"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000782"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2017.0150"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10030603"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41528-z"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40813-021-00209-y"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02399-12"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tvjl.2015.03.014"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-5877(97)00095-0"},{"key":"e_1_3_3_52_2","unstructured":"Federal Office of Consumer Protection and Food Safety (BVL). 2020. BVL-Report 14.6 - Bericht zur Resistenzmonitoringstudie 2018: Resistenzsituation bei klinisch wichtigen tierpathogenen Bakterien. Bundesamt f\u00fcr Verbraucherschutz und Lebensmittelsicherheit (BVL) Lebensmittelsicherheit BfVu Berlin"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-1605(03)00124-7"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2672.2011.05193.x"},{"key":"e_1_3_3_55_2","unstructured":"ECDC \/ EFSA \/ EMA. 2021. Third joint inter-agency report on integrated analysis of consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the EU\/EEA JIACRA III. Parma Amsterdam ECDC EFSA EMA Stockholm"},{"key":"e_1_3_3_56_2","volume-title":"Integrated surveillance of antimicrobial resistance in foodborne bacteria: application of a one health approach","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. 2017. Integrated surveillance of antimicrobial resistance in foodborne bacteria: application of a one health approach. World Health Organization, Geneva."},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00313"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1812.120513"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2014.10.010"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.1089\/vbz.2016.2038"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.plasmid.2018.09.010"},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2017.0371"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2006.03.026"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00103-018-2724-0"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-022-01100-4"},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-015-0433-4"},{"key":"e_1_3_3_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuac031"},{"key":"e_1_3_3_68_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004776"},{"key":"e_1_3_3_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/zph.12318"},{"key":"e_1_3_3_70_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000541"},{"key":"e_1_3_3_71_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00336"},{"key":"e_1_3_3_72_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.03916-14"},{"key":"e_1_3_3_73_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02789-07"},{"key":"e_1_3_3_74_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw308"},{"key":"e_1_3_3_75_2","doi-asserted-by":"publisher","DOI":"10.1111\/tbed.12799"},{"key":"e_1_3_3_76_2","doi-asserted-by":"publisher","DOI":"10.2903\/j.efsa.2023.7867"},{"key":"e_1_3_3_77_2","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.023234-0"},{"key":"e_1_3_3_78_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28342-4"},{"key":"e_1_3_3_79_2","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2014.0037"},{"key":"e_1_3_3_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2017.12.002"},{"key":"e_1_3_3_81_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-016-0850-1"},{"key":"e_1_3_3_82_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.00559-11"},{"key":"e_1_3_3_83_2","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msx052"},{"key":"e_1_3_3_84_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-017-1260-8"},{"key":"e_1_3_3_85_2","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10020097"},{"key":"e_1_3_3_86_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.02812-18"},{"key":"e_1_3_3_87_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5331.1453"},{"key":"e_1_3_3_88_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkab301"}],"container-title":["Applied and Environmental Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aem.01386-24","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/aem.01386-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T13:01:18Z","timestamp":1750251678000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/aem.01386-24"}},"subtitle":[],"editor":[{"given":"Martha","family":"Vives","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":87,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,18]]}},"alternative-id":["10.1128\/aem.01386-24"],"URL":"https:\/\/doi.org\/10.1128\/aem.01386-24","relation":{},"ISSN":["0099-2240","1098-5336"],"issn-type":[{"value":"0099-2240","type":"print"},{"value":"1098-5336","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"2024-07-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e01386-24"}}